ACR2021 - Day5a
Rheumnow Podcast

ACR2021 - Day5a

2021-11-10

Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim
Potpourri of Biosimilar Trials: Dr. Jonathan Kay
Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao

Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free